RecallDepth
Class II Terminated

Lupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilled dual-chamber syringe, 22.5 mg for 3-month administration, Rx only, Manufactured for: AbbVie Inc., North Chicago, IL 60064; by: Takeda Pharmaceutical Company Limited, Osaka, Japan 540-8645; NDC 0074-3346-03, UPC 3 00743 34603 9.

Company
Abbvie Inc.
Recall Initiated
March 10, 2014
Posted
May 7, 2014
Recall Number
D-1287-2014
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
7362 kits
Firm Location
North Chicago, IL, United States

Reason for Recall

Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.

Distribution

Nationwide and Puerto Rico

Lot / Code Info

Lot #: 1014204, Exp 10/11/15; 1014485, Exp 12/11/16; and 1015007, Exp 12/06/16

More recalls by Abbvie Inc.

View all recalls by this company →

Other recent Class II Drug recalls